Clincosm LogoSign in Get a demo

Improving Methadone Maintenance Treatment Compliance and Outcomes in China

Sponsor
University of California, Los Angeles (Other)
Overall Status
Completed
CT.gov ID
NCT01270113
Collaborator
National Institute on Drug Abuse (NIDA) (NIH)

Study Details

Study Description

Brief Summary

China faces the challenge of dual epidemics of drug use and HIV/AIDS. In responding to concerns of high rates of HIV/AIDS and other medical consequences among heroin users, China has recently implemented methadone maintenance treatment (MMT) programs nationwide. One problem noted with this rapid expansion is that the dropout rates from MMT have been high. The proposed study will adapt a motivational incentives (MI) intervention developed in the United States for use in Chinese MMT settings and will pilot test its effectiveness in improving treatment compliance and outcomes. The study's primary aims are: 1. to adapt a motivational incentives intervention in MMT in China, and 2. to experimentally pilot test the motivational incentives intervention. A secondary aim is to explore factors that may influence the outcomes of MMT that incorporates a motivational incentives intervention. It is hypothesized that the MI intervention can be adapted to Chinese settings and that it will optimize the positive outcomes of MMT in reducing HIV risks among heroin abusers. The collaborative team includes researchers in American and Chinese institutes (UCLA/Johns Hopkins/Washington, Shanghai Mental Health Center, Yunnan Institute for Drug Abuse), officials from national and local Chinese Centers for Disease Control and Prevention, and providers in local MMT clinics in Shanghai and Yunnan.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: contingency management
 N/A

Study Design

Study Type:
Interventional
Official Title:
Improving Methadone Maintenance Treatment Compliance and Outcomes in China

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All

    Inclusion Criteria:adult patients entering the participating MMT clinics during the recruitment period who are dependent on heroin and who are willing to participate in the study.

    Exclusion Criteria:Patients who are diagnosed with severe mental illness will not be eligible to participate.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of California, Los Angeles
    • National Institute on Drug Abuse (NIDA)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01270113
    Other Study ID Numbers:
    • DESPR DA025252
    • 5R21DA025252-02
    First Posted:
    Jan 5, 2011
    Last Update Posted:
    Jan 5, 2011
    Last Verified:
    Dec 1, 2010

    Study Results

    No Results Posted as of Jan 5, 2011